Understanding the evolution of healthcare costs by disease is critical for stakeholders across the healthcare landscape. This presentation will provide a detailed analysis of healthcare expenditure trends for both commercial and Medicare populations from 2021 to 2023, segmented by year, region (Northeast, South, West, and Central), and categorized by disease. Using a comprehensive dataset, we will highlight key drivers of cost variations, including treatment advancements and changes in care delivery.
The session will also explore how pharmaceutical manufacturers and life science companies can leverage this data to refine their strategic planning, product development, and market access strategies. For actuaries, the findings present valuable insights into designing cost-effective health plans and managing risk.
After this session, attendees will be able to:
Identify key healthcare cost trends by disease and region across commercial and Medicare populations.
Interpret underlying drivers of cost variations, such as treatment advancements and care delivery changes.
Apply these insights to inform strategic planning, product development, and risk management.